| ||||||||||||||||||||||||||
| Pronunciation |
 (PLAS
mah PROE teen FRAK
shun) |
 |
| U.S. Brand Names |
| Plasmanate®; Plasma-Plex®; Plasmatein®; Protenate® |
|
| Generic Available |
|
No |
|
| Pharmacological Index |
|
Blood Product Derivative |
|
| Use |
|
Plasma volume expansion and maintenance of cardiac output in the treatment of certain types of shock or impending shock |
|
| Pregnancy Risk Factor |
|
C |
|
| Usual Dosage |
|
I.V.: 250-1500 mL/day |
|
| Administration |
|
Albumin administration must be completed within 6 hours after entering the container, provided that administration is begun within 4 hours of entering the container; rapid infusion may cause vascular overload |
|
| Nursing Implications |
|
5% albumin and 5% plasma protein fraction can usually be used interchangeably |
|
| Dosage Forms |
|
Injection: 5% (50 mL, 250 mL, 500 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
